Tag: Neurodegenerative Diseases
The End of Cassava Sciences and its Alzheimer’s Drug: Lingering Damage
The story of Cassava Sciences came to a disappointing end on Monday when their experimental drug for Alzheimer's disease, simufilam, was found to be...
Assessing the Cost-Effectiveness of Alzheimer’s Drug Donanemab in the U.K.
The recent decision by the U.K.'s National Institute for Health and Care Excellence (NICE) regarding the cost-effectiveness of the Alzheimer's drug Donanemab, also known...
Unlocking Faster Dementia Diagnoses Using AI and Brain Waves
Dementia is a growing concern, and Mayo Clinic researchers believe that artificial intelligence (AI) can help with faster and earlier diagnoses. By combining AI...
Accurate Alzheimer’s Diagnosis: Blood Test with 90% Success Rate
Scientists have recently made a significant advancement in the quest for a simple blood test to accurately diagnose Alzheimer's disease. The study, published in...
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
